3rd edition of the European CAR T-cell Meeting
CAR-T-cell treatment is thought to be one of the most promising therapies in development for the treatment of myeloma. There are several ongoing clinical trials evaluating the safety and efficacy of CAR-T-cells, and some of the studies with very encouraging results.